Novo Nordisk’s consensus analyst price target has recently experienced a slight adjustment, moving down from DKK 444.05 to DKK 438.59. This change comes amid a blend of optimism and caution, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback